BioControl Medical Completes Enrollment In The INOVATE-HF Study Of The Cardiofit System To Treat Heart Failure

YEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--BioControl Medical, a medical technology company that develops implantable medical devices to treat disorders of the autonomic nervous system, has completed enrollment in its INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical trial evaluating the CardioFit® system for the treatment of congestive heart failure (HF). INOVATE-HF has enrolled a total of 725 patients at 86 centers in the United States and Europe, making it the largest prospective, randomized device study to evaluate the treatment of HF with vagus nerve stimulation.

Help employers find you! Check out all the jobs and post your resume.